Sep 2026· Brain : a journal of neurology· 0 citations
Medicine
TL;DR
It is suggested that the interaction between epigenetic and epitranscriptomic mechanisms is a key factor in determining risk and resilience for neuropsychiatric disorders, and offers new directions for future research and therapy development.
Abstract
Epigenetic and epitranscriptomic mechanisms work together to control gene expression, which is essential for brain development, synaptic plasticity, and the risk of neuropsychiatric disorders. Traditional epigenetic processes, such as DNA methylation and histone modifications, alter chromatin structure to regulate gene accessibility. On the other hand, epitranscriptomic marks such as N6-methyladenosine (m6A) affect RNA metabolism after transcription. Studies in both neural and non-neural systems show that these layers of regulation interact in both directions and together shape gene expression. This review looks at how m6A-modified non-coding RNAs, including chromosome-associated regulatory RNAs (carRNAs), enhancer RNAs (eRNAs), microRNAs, and circular RNAs, work with chromatin to influence genome function, including chromatin accessibility, histone modifications, and the overall structure of the genome. It also covers recent discoveries about how eRNAs form R-loops, how m6A affects RNA stability, and how these processes are involved in neuronal signaling and plasticity. Many of these findings come from studies outside the nervous system and need more research in neuropsychiatric disease models. By bringing together established knowledge and new ideas, this review suggests that the interaction between epigenetic and epitranscriptomic mechanisms is a key factor in determining risk and resilience for neuropsychiatric disorders, and offers new directions for future research and therapy development.
It is argued that future progress will depend on cell-resolved longitudinal multi-omics, causal epigenome editing, human tissue validation, and biomarker studies designed around prespecified clinical utility rather than statistical association alone.
Jia-Nan You, Lei Li· Frontiers in Genetics· 0 citations
Abnormal epigenetic modifications are involved in central nervous system (CNS) diseases. Histones play a crucial role in chromatin structure and function, whose post-translational modifications significantly impact gene expression and chromatin dynamics. Histone acetylation, governed by the balance between histone acet...
Xiao-Ming Xin, Ling-Juan Wu, Mei-Chen Liu et al.· Frontiers in Molecular Neuro...· 0 citations
ABSTRACT Once considered somewhere between inert (‘junk DNA’) and parasitic (‘selfish genetic elements’), transposable elements (TEs) are increasingly appreciated as inseparable from the healthy functioning of eukaryotic genomes. The ubiquitous TE sequences that make up about half of the human genome are sources of the...
Corinne Smith, Peter J. Hamilton· Epigenetics· 0 citations
DNA methylation is a key epigenetic mechanism that mediates gene expression and informs cellular identity. Methyl-CpG binding protein 2 (MeCP2) is a protein capable of recognizing and interpreting the methylated DNA code to bring about phenotypic outcomes through co-factor interactions. Altered DNA methylation patterns...
Grace C. Stroman, Clara Mellows, K. Pruitt· Frontiers in epigenetics and...· 0 citations
A narrative review summarizes the current understanding of RNA modifications, with a particular focus on m6A and m5C in male reproductive biology, and discusses and highlights their roles in pathological reprogramming of spermatogenesis and underscore their potential as diagnostic biomarkers and therapeutic targets for...
S. Salih, A. Al-Hendy, Qi-Wei Yang· Biology· 0 citations
The bidirectional interplay between lncRNAs and the epitranscriptomic machinery is examined, emerging principles of epigenome-epitranscriptome integration, feedback regulation, and spatial organization are highlighted, and their implications for cancer progression and therapeutic response are explored.
C. Maheshwari, R. Nadhan, Karthik Nath et al.· Cancer Letters· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.